These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1480591)

  • 1. [Interrelationships between prolactin and the renin-aldosterone system in patients with various endocrine diseases].
    Atamanova TM; Egart FM; Dobracheva AL
    Probl Endokrinol (Mosk); 1992; 38(5):43-5. PubMed ID: 1480591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the circulating renin-angiotensin system on prolactin release in humans.
    Denolle T; Rohmer V; Saint-Adnré JP; Guyene TT; Galland F; Bigorgne JC; Schambelan M; Corvol P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):288-92. PubMed ID: 2104627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between endogenous hyperprolactinaemia and plasma aldosterone.
    Re RN; Kourides IA; Weihl AC; Maloof F
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):187-93. PubMed ID: 106989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renin-angiotensin system and the endocrine system].
    Kondo K; Sokabe H
    Rinsho Byori; 1984 Jan; Spec No 58():20-8. PubMed ID: 6088845
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity and endocrine disease.
    Kokkoris P; Pi-Sunyer FX
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):895-914. PubMed ID: 14711067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Bravo-Henríquez A
    Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone increases plasma norepinephrine in man.
    Morley JE; Tuck ML; Mayes DM; Rosenblatt S; Hershman JM
    Horm Res; 1981; 14(1):18-23. PubMed ID: 6790402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma renin activity and aldosterone behavior in critically ill patients].
    Jungmann E; Schifferdecker E; Rümelin A; Althoff PH; Schöffling K
    Klin Wochenschr; 1987 Jan; 65(2):87-91. PubMed ID: 3104659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system].
    Rom-Bugoslavskaia ES; Komarova IV
    Probl Endokrinol (Mosk); 1986; 32(2):13-6. PubMed ID: 2424003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
    Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH
    Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The renin-angiotensin-aldosterone (RAA) system in endocrine diseases].
    Zdrojewicz Z
    Wiad Lek; 1990 Jul; 43(13):679-84. PubMed ID: 2256331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of TRH on prolactin, plasma renin activity, water and electrolyte excretion in normal males.
    Epstein S; van Zyl-Smit R; le Roith D; Vinik A; Pimstone B
    Horm Metab Res; 1977 Nov; 9(6):495-8. PubMed ID: 412766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reaction of prolactin to TRH in various diseases].
    Demura R; Saisu S; Takano K; Shigeshiro K; Odagiri E
    Horumon To Rinsho; 1974 Oct; 22(10):1167-75. PubMed ID: 4217232
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
    Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
    Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lactotropic and thyrotropic functions of the hypophysis in polycystic ovary syndrome].
    Tudose TI; Zelenetskaia VS; Kozlov GI; Pishchulin AA; Dobracheva AD
    Probl Endokrinol (Mosk); 1986; 32(3):3-7. PubMed ID: 3090541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the renin-angiotensin-aldosterone system in the pathogenesis of edema formation in chronic obstructive pulmonary disease].
    Zeng GB; Duan SF
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):283-5, 314-5. PubMed ID: 2805968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.